Before use, read the leaflet containing indications, contraindications, data and information concerning adverse effects and dosage, as well as information concerning the use of the medicinal product, or consult a doctor or a pharmacist, because each drug used inappropriately poses a risk for your life and health.
Composition: 1 tablet contains 30 mg ambroxol hydrochloride; 1 effervescent tablet contains 60 mg ambroxol hydrochloride; 5 ml of syrup contains 15 mg ambroxol hydrochloride.
Indications: Mucolytic treatment in acute and chronic bronchial and pulmonary disorders associated with disturbances of mucus production and transport.
Contraindications: hypersensitivity to ambroxol
Responsible entity: Berlin - Chemie AG, Glienicker Weg 125; 12489 Berlin, Germany
Scientific information about the drug: Berlin-Chemie/ Menarini Polska Sp. z o.o., ul. Cybernetyki 7 02-677 Warszawa, tel. (022) 566 21 00, fax (022) 566 21 01